298 related articles for article (PubMed ID: 35667922)
21. Generation of a human induced pluripotent stem cell line derived from a Parkinson's disease patient carrying SNCA duplication.
Suzuki H; Egawa N; Kondo T; Imamura K; Enami T; Tsukita K; Suga M; Shibukawa R; Okanishi Y; Uchiyama T; Inoue H; Takahashi R
Stem Cell Res; 2020 May; 45():101828. PubMed ID: 32413791
[TBL] [Abstract][Full Text] [Related]
22. Transcriptomics analysis of human iPSC-derived dopaminergic neurons reveals a novel model for sporadic Parkinson's disease.
Krauskopf J; Eggermont K; Madeiro Da Costa RF; Bohler S; Hauser D; Caiment F; de Kok TM; Verfaillie C; Kleinjans JC
Mol Psychiatry; 2022 Oct; 27(10):4355-4367. PubMed ID: 35725899
[TBL] [Abstract][Full Text] [Related]
23. Advanced human iPSC-based preclinical model for Parkinson's disease with optogenetic alpha-synuclein aggregation.
Kim MS; Ra EA; Kweon SH; Seo BA; Ko HS; Oh Y; Lee G
Cell Stem Cell; 2023 Jul; 30(7):973-986.e11. PubMed ID: 37339636
[TBL] [Abstract][Full Text] [Related]
24. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
Hennis MR; Marvin MA; Taylor CM; Goldberg MS
Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells.
Stoddard-Bennett T; Reijo Pera R
Cells; 2019 Jan; 8(1):. PubMed ID: 30621042
[TBL] [Abstract][Full Text] [Related]
26. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
[TBL] [Abstract][Full Text] [Related]
27. Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson's disease.
Coccia E; Ahfeldt T
Stem Cell Res Ther; 2021 Apr; 12(1):253. PubMed ID: 33926571
[TBL] [Abstract][Full Text] [Related]
28. The multifaceted role of LRRK2 in Parkinson's disease: From human iPSC to organoids.
Oun A; Sabogal-Guaqueta AM; Galuh S; Alexander A; Kortholt A; Dolga AM
Neurobiol Dis; 2022 Oct; 173():105837. PubMed ID: 35963526
[TBL] [Abstract][Full Text] [Related]
29. Metabolic alterations in Parkinson's disease astrocytes.
Sonninen TM; Hämäläinen RH; Koskuvi M; Oksanen M; Shakirzyanova A; Wojciechowski S; Puttonen K; Naumenko N; Goldsteins G; Laham-Karam N; Lehtonen M; Tavi P; Koistinaho J; Lehtonen Š
Sci Rep; 2020 Sep; 10(1):14474. PubMed ID: 32879386
[TBL] [Abstract][Full Text] [Related]
30. Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations.
Momcilovic O; Sivapatham R; Oron TR; Meyer M; Mooney S; Rao MS; Zeng X
PLoS One; 2016; 11(5):e0154890. PubMed ID: 27191603
[TBL] [Abstract][Full Text] [Related]
31. Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson's disease.
Drouin-Ouellet J; Legault EM; Nilsson F; Pircs K; Bouquety J; Petit F; Shrigley S; Birtele M; Pereira M; Storm P; Sharma Y; Bruzelius A; Vuono R; Kele M; Stoker TB; Ottosson DR; Falk A; Jakobsson J; Barker RA; Parmar M
Stem Cell Reports; 2022 Oct; 17(10):2203-2219. PubMed ID: 36150382
[TBL] [Abstract][Full Text] [Related]
32. Impairment of proteasome and anti-oxidative pathways in the induced pluripotent stem cell model for sporadic Parkinson's disease.
Chang KH; Lee-Chen GJ; Wu YR; Chen YJ; Lin JL; Li M; Chen IC; Lo YS; Wu HC; Chen CM
Parkinsonism Relat Disord; 2016 Mar; 24():81-8. PubMed ID: 26797011
[TBL] [Abstract][Full Text] [Related]
33. Parkinson's disease: an update on preclinical studies of induced pluripotent stem cells.
Valadez-Barba V; Juárez-Navarro K; Padilla-Camberos E; Díaz NF; Guerra-Mora JR; Díaz-Martínez NE
Neurologia (Engl Ed); 2023; 38(9):681-694. PubMed ID: 37858889
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial Phenotypes in Parkinson's Diseases-A Focus on Human iPSC-Derived Dopaminergic Neurons.
Heger LM; Wise RM; Hees JT; Harbauer AB; Burbulla LF
Cells; 2021 Dec; 10(12):. PubMed ID: 34943944
[TBL] [Abstract][Full Text] [Related]
35. Generation of three induced pluripotent stem cell lines from a Parkinson's disease patient with mutant PARKIN (p. C253Y).
Tariq M; Liu H; Ibañez DP; Li Y; Chen S; Jiang M; Fan W; Zhao P; Luo Z; Wang D; Kanwal S
Stem Cell Res; 2020 May; 45():101822. PubMed ID: 32387897
[TBL] [Abstract][Full Text] [Related]
36. Analysis of dopaminergic neuronal dysfunction in genetic and toxin-induced models of Parkinson's disease in Drosophila.
Navarro JA; Heßner S; Yenisetti SC; Bayersdorfer F; Zhang L; Voigt A; Schneuwly S; Botella JA
J Neurochem; 2014 Nov; 131(3):369-82. PubMed ID: 25040725
[TBL] [Abstract][Full Text] [Related]
37. ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons.
Fernandes HJ; Hartfield EM; Christian HC; Emmanoulidou E; Zheng Y; Booth H; Bogetofte H; Lang C; Ryan BJ; Sardi SP; Badger J; Vowles J; Evetts S; Tofaris GK; Vekrellis K; Talbot K; Hu MT; James W; Cowley SA; Wade-Martins R
Stem Cell Reports; 2016 Mar; 6(3):342-56. PubMed ID: 26905200
[TBL] [Abstract][Full Text] [Related]
38. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
[TBL] [Abstract][Full Text] [Related]
39. Modeling Parkinson's Disease Using Induced Pluripotent Stem Cells.
Hu X; Mao C; Fan L; Luo H; Hu Z; Zhang S; Yang Z; Zheng H; Sun H; Fan Y; Yang J; Shi C; Xu Y
Stem Cells Int; 2020; 2020():1061470. PubMed ID: 32256606
[TBL] [Abstract][Full Text] [Related]
40. Back and to the Future: From Neurotoxin-Induced to Human Parkinson's Disease Models.
Airavaara M; Parkkinen I; Konovalova J; Albert K; Chmielarz P; Domanskyi A
Curr Protoc Neurosci; 2020 Mar; 91(1):e88. PubMed ID: 32049438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]